GLS and endolymphatic hydrops: Additionally, GLS inhibitor CB-839 and inhibitor of the IL-1β receptor Anakinra alleviated the hearing loss and vestibular dysfunction, and reduced the level of glutamate in the endolymphatic hydrop mice.